Home/Pipeline/TLM-003

TLM-003

Myopia Progression

Phase 2Active

Key Facts

Indication

Myopia Progression

Phase

Phase 2

Status

Active

Company

Laboratoires Théa

About Laboratoires Théa

Laboratoires Théa is a privately held, fully integrated ophthalmology company with a global commercial footprint and a vertically integrated '100% made in Europe' manufacturing model. Its core business is built on a portfolio of commercial products addressing common eye conditions like dry eye, glaucoma, allergies, and infections, while actively investing in a diversified R&D pipeline through internal development and strategic partnerships. The company is led by its founding family, emphasizes corporate social responsibility with a stated carbon neutrality goal by 2045, and is expanding its pipeline into novel therapeutic areas such as myopia progression and genetic retinal diseases.

View full company profile

Therapeutic Areas

Ophthalmology Dry Eye Disease Glaucoma Ocular Allergy Myopia Progression Genetic Retinal Diseases Eye Infections Ocular Inflammation

Other Myopia Progression Drugs

Drug	Company	Phase	Status
OT-101	Ocumension Therapeutics	Phase 3	Active
Myopia Control Therapeutic Lenses	Clerio Vision	Development	Active
TODDD™ Platform	Amorphex Therapeutics	Pre-clinical	Active